12,075
Total Claims
$1.4M
Drug Cost
1,190
Beneficiaries
$1,212
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-21%
Cost per patient vs peers
$1,212 vs $1,524 avg
+9%
Brand preference vs peers
14.9% vs 13.7% avg
Brand vs Generic
85% generic
Brand: 1,800 claims · $1.2M
Generic: 10,275 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 785 | $707K |
| Sacubitril/Valsartan | 238 | $225K |
| Nebivolol Hcl | 880 | $55K |
| Icosapent Ethyl | 68 | $54K |
| Rivaroxaban | 35 | $42K |
| Azilsartan Medoxomil | 66 | $28K |
| Dronedarone Hcl | 12 | $25K |
| Dapagliflozin Propanediol | 25 | $23K |
| Pitavastatin Calcium | 44 | $21K |
| Azilsartan Med/Chlorthalidone | 66 | $21K |
| Alirocumab | 36 | $19K |
| Evolocumab | 18 | $14K |
| Ticagrelor | 27 | $14K |
| Olmesartan Medoxomil | 677 | $12K |
| Rosuvastatin Calcium | 659 | $9,033 |
Prescribing Profile
66
Unique Drugs
$996K
Patient Profile
76
Avg Age
51%
Female
1.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data